>BS/BA Chem/Span from Washburn Univ 1988 >PhD at St Louis University in 1993 >Post-doc at SKB-3.5 yrs >Staff Scientist at the NCI-3 year >Sr Res Scientist at Bayer Corp-3 yrs >Assoc Dir & TA lead for Diabetes/Obesity at Merck & Co.-6 yr >Dir Global Proj Mng and Leadership-current
Ph.D.-Neuroscience (UPenn). Merck Project Management (2001)- early/late-stage programs in Neuroscience, Oncology, Infectious Disease. Currently: Manager for Sylatron/PegIntron, ID Franchise Pipeline Lead (interface between teams/management, manage profit planning/prioritization), Due Diligence.
Mann Fung, Johnson & Johnson Pharmaceutical Research & Development, LLC, United States
Education: Chemistry degree from Princeton Univ, PhD in Analytical Chemistry from Univ of Kentucky, 16+ years at Pfizer. The last 6 years spent as Pharm Sciences team leader, including Xalkori and Inlyta, each filed in 2011. Currently Sr Director responsible for the Oncology portfolio in Pharm Sci.
Description
This session will describe actual case studies of successful oncology development programs. Presenters will focus on the key success factors to a productive collaboration and lessons learned from their own experiences.
Learning Objectives: Discuss key planning components involved in a global oncology program Describe the functional area interaction/collaboration necessary to execute a global oncology program.